You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯港股聚焦(7.01)︱恆大半年銷售及回款創歷史同期紀錄 雅生活服務H股全流通獲中證監批准
格隆匯 07-01 23:48

【AH股】

君實生物(01877.HK):科創板定價55.50元/股

中州證券(01375.HK):非公開發行新A股申請獲中證監核准批覆

【停復牌】

年年卡(03773.HK)預期中期盈利不少於1500萬元 2日復牌

凱華集團(00275.HK)延遲刊發2020年年報 繼續停牌

【運營數據】

中國恆大(03333.HK):6月合約銷售額升51.3%至760.5億元 上半年銷售及回款刷新歷史同期紀錄

碧桂園(02007.HK)6月權益合同銷售額達561.1億元

【財務數據】

受累投資物業公平值虧損 森信紙業集團(00731.HK)年度盈利降58.4%

匯能集團(01539.HK)年度業績由盈轉虧至1.1億港元

新昌創展控股(01781.HK)年度淨虧2.97億港元 核數師不發表意見

久康國際(00850.HK)年度淨虧收窄70.9%至1.17億港元

中國再生醫學(08158.HK)年度淨虧收窄66.9%至3.95億港元

汛和集團(01591.HK)年度淨虧擴大31.5%至3305.3萬港元

中國支付通(08325.HK)年度淨虧擴大130.3%至7.10億港元 核數師出具非標意見

【重大事項】

華領醫藥宣佈Dorzagliatin與二甲雙胍聯合用藥III期註冊臨牀研究24周核心研究取得正面結果

雅生活服務(03319.HK):H股全流通及增發境外上市外資股申請獲中證監批准

思捷環球(00330.HK):有意未來三個月執行重組計劃內的重組措施

維亞生物(01873.HK):3.92億元成功競投浦東新區工廈物業

【併購出售】

中國心連心化肥(01866.HK)完成收購瑞誠科技51%股權

中國心連心化肥(01866.HK):央企扶貧基金2億元投資河南心連心化學落實

宏華集團(00196.HK):3.1億元出售2套6000HP電動壓裂泵及附屬配套設備

麗珠醫藥(01513.HK):完成出售尼科公司19.99%股權 預計增加淨利潤8523.99萬元

【分紅付息】

建設銀行(00939.HK)2019年度A股派息每10股3.2元 股權登記日7月9日

【人事變動】

華興資本控股(01911.HK)委任叢林為集團總裁

前橋水聯席CEO梅愛苓出任匯豐控股(00005.HK)獨董

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account